Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2016-07-26 Management Reports
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Operational Update 6 pages 1.2MB
Management Reports Classification · 95% confidence The document is titled 'Operational Update' and dated July 27, 2016. It provides detailed progress information on the company's internal oncology program, technical milestones, development timelines, collaborations, and strategic plans. The content is focused on operational and developmental progress rather than financial results or regulatory compliance. There are no financial statements, earnings highlights, or formal report structures typical of Annual Reports (10-K), Interim Reports (IR), or Earnings Releases (ER). It also does not contain any voting results, board changes, or legal proceedings. The document is a comprehensive update on company operations and development progress, which aligns with the nature of a Management Report (MDA), where management explains business trends, progress, and outlook. The length (about 15,000 characters) and detailed content support this classification rather than a brief announcement or presentation. Therefore, the most appropriate classification is Management Reports (MDA).
2016-07-26 English
Appendix 4C - quarterly 4 pages 118.2KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C' and is described as a 'Quarterly report for entities admitted on the basis of commitments.' It contains detailed financial data including consolidated statement of cash flows, payments to directors, financing facilities, reconciliation of cash, and compliance statements. The presence of quarterly financial data and cash flow statements indicates it is a comprehensive financial report for a period shorter than a full fiscal year. The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q4 2016
2016-07-25 English
Chief Executive Officer Resignation 1 page 20.0KB
Board/Management Information Classification · 95% confidence The document is a formal announcement regarding the resignation of the Chief Executive Officer of Phylogica Limited. It details the CEO's departure, the board's interim management plans, and the search for new leadership. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no legal proceedings, and no report attachments. The content focuses solely on management changes at the board/executive level. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and does not indicate it is a report or announcement of a report publication, so it is not RPA or RNS. Confidence is high given the clear subject matter and absence of other report types.
2016-07-17 English
Final Director's Interest Notice 2 pages 68.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and options, and notes the date the director ceased to be a director. This is a report of personal share transactions and holdings by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial results or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2016-07-17 English
Option Expiry 1 page 19.7KB
Capital/Financing Update Classification · 95% confidence The document is a brief announcement from Phylogica Limited regarding the expiration of listed options that were not exercised. It does not contain financial statements, management discussion, or detailed financial data. The content is about a capital market event related to options expiring unexercised, which fits best under capital or financing updates. The document length is short and it is not a report or a regulatory filing but a specific update on capital instruments.
2016-06-30 English
Change of Director's Interest Notice 3 pages 75.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including direct and indirect interests, dates of changes, and nature of transactions such as lapsing options. The content is focused on reporting personal share transactions by a director, which aligns with insider trading disclosures. The document length is 4578 characters, and it contains detailed information about the director's securities interests and changes. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2016-06-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.